Stoke Therapeutics, Inc. (STOK) Net margin 2022–2025
Stoke Therapeutics, Inc. (STOK) net profit margin by fiscal year — reported net income divided by reported revenue.
-3.7%FY2025 · since FY2022: -814.7% → -3.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3.7% | +239.7 pp |
| FY2024 | -243.4% | +949.1 pp |
| FY2023 | -1192.5% | -377.7 pp |
| FY2022 | -814.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More STOK financial trends
STOK RevenueSTOK Net incomeSTOK Gross profitSTOK Gross marginSTOK Operating incomeSTOK Operating marginSTOK Operating cash flowSTOK Free cash flowSTOK Capital expendituresSTOK Return on equitySTOK Stock buybacksSTOK Dividends paidSTOK Total assetsSTOK Total liabilitiesSTOK Shareholders’ equitySTOK overview →